Pharmacological characterisation of acid-induced muscle allodynia in rats

European Journal of Pharmacology

Volumn 487, Issue 1-3, 2004, Pages 93-103

  Nielsen, Alexander Norup ^a   Mathiesen, Claus ^a   Blackburn Munro, Gordon ^a  

^a NEUROSEARCH A S   (Denmark)

Author keywords

Central sensitisation; Fibromyalgia; GABA (gamma aminobutyric acid); Glutamate receptor antagonist; Muscle pain; Na+ channel blockers

Indexed keywords

2 [5 (4 DIMETHYLSULFAMOYLPHENYL) 6,7,8,9 TETRAHYDRO 8 METHYL 2 OXO 1H PYRROLO[3,2 H]ISOQUINOLIN 3 YLIMINOXY] 4 HYDROXYBUTYRIC ACID; ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARPROFEN; CYCLOOXYGENASE 2 INHIBITOR; DIAZEPAM; FLUPIRTINE; GLUTAMATE RECEPTOR ANTAGONIST; KETAMINE; LAMOTRIGINE; MEXILETINE; MORPHINE; MU OPIATE RECEPTOR AGONIST; POTASSIUM CHANNEL KCNQ1; POTASSIUM CHANNEL STIMULATING AGENT; RETIGABINE; SODIUM CHANNEL BLOCKING AGENT; UNCLASSIFIED DRUG;

ALLODYNIA; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; MALE; MUSCULOSKELETAL DISEASE; MYALGIA; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; WITHDRAWAL REFLEX;

ACIDS; ANALGESICS, OPIOID; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATAXIA; CARBAZOLES; CHRONIC DISEASE; COLD; DIAZEPAM; EXCITATORY AMINO ACID ANTAGONISTS; FUNCTIONAL LATERALITY; GABA MODULATORS; HEAT; HYPERALGESIA; MALE; MORPHINE; MUSCULAR DISEASES; MUSCULOSKELETAL EQUILIBRIUM; PAIN; PAIN MEASUREMENT; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUTAMATE; SODIUM CHANNEL BLOCKERS; SYNAPTIC TRANSMISSION;

EID: 1642285193     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.01.017     Document Type: Article

References (38)

1. Arner S., Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 33:1988;11-23.
2. Blackburn-Munro G., Jensen B.S. The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain. Eur. J. Pharmacol. 460:2003;109-116.
3. + channel blockers in the formalin test. Eur. J. Pharmacol. 445:2002;231-238.
4. Brown B.S., Yu S.P. Modulation and genetic identification of the M channel. Prog. Biophys. Mol. Biol. 73:2000;135-166.
5. Clare J.J., Tate S.N., Nobbs M., Romanos M.A. Voltage-gated sodium channels as therapeutic targets. Drug Discov. Today. 5:2000;506-520.
6. Danysz W., Essmann U., Bresink I., Wilke R. Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol. Biochem. Behav. 48:1994;111-118.
7. Erichsen H.K., Blackburn-Munro G. Pharmacological characterisation of the spared nerve injury model of neuropathic pain. Pain. 98:2002;151-161.
8. Erichsen H.K., Hao J.X., Xu X.J., Blackburn-Munro G. A comparison of the antinociceptive effects of voltage-activated Na(+) channel blockers in two rat models of neuropathic pain. Eur. J. Pharmacol. 458:2003;275-282.
9. Fundytus M.E. Glutamate receptors and nociception: implications for the drug treatment of pain. CNS Drugs. 15:2001;29-58.
10. Gracely R.H., Petzke F., Wolf J.M., Clauw D.J. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum. 46:2002;1333-1343.
11. Graven-Nielsen T., Aspegren K.S., Henriksson K.G., Bengtsson M., Sorensen J., Johnson A., Gerdle B., Arendt-Nielsen L. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain. 85:2000;483-491.
12. Gutstein H.B., Rubie E.A., Mansour A., Akil H., Woodgett J.R. Opioid effects on mitogen-activated protein kinase signaling cascades. Anesthesiology. 87:1997;1118-1126.
13. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
14. Ilyin V.I., Carlin K.P., Hodges D.D., Robledo S., Woodward R.M. Flupirtine-a positive modulator of heteromeric KCNQ2/Q3 channels. Neurosci. Meet. 2002;. Program No. 758.1 (10-7-2002, Abstract).
15. Jentsch T.J. Neuronal KCNQ potassium channels: physiology and role in disease. Nat. Rev., Neurosci. 1:2000;21-30.
16. 2+ block via activation of voltage independent potassium channels. Rapid communication. J. Neural Transm. 106:1999;857-867.
17. + currents: quantitative distinction from phenytoin and possible therapeutic implications. Mol. Pharmacol. 51:1997;1077-1083.
18. Mathiesen C., Varming T., Jensen L.H. In vivo and in vitro evaluation of AMPA receptor antagonists in rat hippocampal neurones and cultured mouse cortical neurones. Eur. J. Pharmacol. 353:1998;159-167.
19. Nakamura-Craig M., Follenfant R.L. Effect of lamotrigine in the acute and chronic hyperalgesia induced by PGE2 and in the chronic hyperalgesia in rats with streptozotocin-induced diabetes. Pain. 63:1995;33-37.
20. Price D.D., Staud R., Robinson M.E., Mauderli A.P., Cannon R., Vierck C.J. Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain. 99:2002;49-59.
21. Radhakrishnan R., More S.A., Sluka K.A. Unilateral carageenan into muscle or joint induces chronic bilateral hyperalgesia in rats. Pain. 104(3):2003;567-577.
22. + channels and the molecular pathogenesis of epilepsy: implications for therapy. Trends Neurosci. 23:2000;393-398.
23. Roughan J.V., Flecknell P.A. Behavioural effects of laparotomy and analgesic effects of ketoprofen and carprofen in rats. Pain. 90:2001;65-74.
24. Rundfeldt C., Netzer R. Investigations into the mechanism of action of the new anticonvulsant retigabine. Interaction with GABAergic and glutamatergic neurotransmission and with voltage gated ion channels. Arzneim.-Forsch. 50:2000;1063-1070.
25. Simmons R.M., Li D.L., Hoo K.H., Deverill M., Ornstein P.L., Iyengar S. Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat. Neuropharmacology. 37:1998;25-36.
26. Skyba D.A., King E.W., Sluka K.A. Effects of NMDA and non-NMDA ionotropic glutamate receptor antagonists on the development and maintenance of hyperalgesia induced by repeated intramuscular injection of acidic saline. Pain. 98:2002;69-78.
27. Sluka K.A., Kalra A., Moore S.A. Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve. 24:2001;37-46.
28. Sluka K.A., Rohlwing J.J., Bussey R.A., Eikenberry S.A., Wilken J.M. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists. J. Pharmacol. Exp. Ther. 302:2002;1146-1150.
29. Szelenyi I., Nickel B. Putative site(s) and mechanism(s) of action of flupirtine, a novel analgesic compound. Postgrad. Med. J. 63(Suppl. 3):1987;57-60.
30. Szelenyi I., Nickel B., Borbe H.O., Brune K. Mode of antinociceptive action of flupirtine in the rat. Br. J. Pharmacol. 97:1989;835-842.
31. Tatulian L., Delmas P., Abogadie F.C., Brown D.A. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J. Neurosci. 21:2001;5535-5545.
32. Van Rijn C.M., Willems-van Bree E. Synergy between retigabine and GABA in modulating the convulsant site of the GABAA receptor complex. Eur. J. Pharmacol. 464:2003;95-100.
33. Wickenden A.D., Zou A., Wagoner P.K., Jegla T. Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells. Br. J. Pharmacol. 132:2001;381-384.
34. Wolfe F., Smythe H.A., Yunus M.B., Bennett R.M., Bombardier C., Goldenberg D.L., Tugwell P., Campbell S.M., Abeles M., Clark P. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 33:1990;160-172.
35. Woolf C.J., Salter M.W. Neuronal plasticity: increasing the gain in pain. Science. 288:2000;1765-1769.
36. Yelin E., Callahan L.F. The economic cost and social and psychological impact of musculoskeletal conditions. National Arthritis Data Work Groups. Arthritis Rheum. 38:1995;1351-1362.
37. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.
38. Zimmermann M. Pathophysiological mechanisms of fibromyalgia. Clin. J. Pain. 7(Suppl. 1):1991;S8-S15.